Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative medicine are greatly needed. The prom...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2021-05-01
|
Series: | Bioactive Materials |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X20302735 |
id |
doaj-2a01c2602eb8404ebc5f272512f81825 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nanbo Liu Xing Ye Bin Yao Mingyi Zhao Peng Wu Guihuan Liu Donglin Zhuang Haodong Jiang Xiaowei Chen Yinru He Sha Huang Ping Zhu |
spellingShingle |
Nanbo Liu Xing Ye Bin Yao Mingyi Zhao Peng Wu Guihuan Liu Donglin Zhuang Haodong Jiang Xiaowei Chen Yinru He Sha Huang Ping Zhu Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration Bioactive Materials 3D bioprinting Stem cell therapy Bioink Heart repair and regeneration |
author_facet |
Nanbo Liu Xing Ye Bin Yao Mingyi Zhao Peng Wu Guihuan Liu Donglin Zhuang Haodong Jiang Xiaowei Chen Yinru He Sha Huang Ping Zhu |
author_sort |
Nanbo Liu |
title |
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration |
title_short |
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration |
title_full |
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration |
title_fullStr |
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration |
title_full_unstemmed |
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration |
title_sort |
advances in 3d bioprinting technology for cardiac tissue engineering and regeneration |
publisher |
KeAi Communications Co., Ltd. |
series |
Bioactive Materials |
issn |
2452-199X |
publishDate |
2021-05-01 |
description |
Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative medicine are greatly needed. The prominent development of tissue engineering using bioactive materials has creatively laid a direct promising foundation. Whereas, how to precisely pattern a cardiac structure with complete biological function still requires technological breakthroughs. Recently, the emerging three-dimensional (3D) bioprinting technology for tissue engineering has shown great advantages in generating micro-scale cardiac tissues, which has established its impressive potential as a novel foundation for cardiovascular regeneration. Whether 3D bioprinted hearts can replace traditional heart transplantation as a novel strategy for treating cardiovascular diseases in the future is a frontier issue. In this review article, we emphasize the current knowledge and future perspectives regarding available bioinks, bioprinting strategies and the latest outcome progress in cardiac 3D bioprinting to move this promising medical approach towards potential clinical implementation. |
topic |
3D bioprinting Stem cell therapy Bioink Heart repair and regeneration |
url |
http://www.sciencedirect.com/science/article/pii/S2452199X20302735 |
work_keys_str_mv |
AT nanboliu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT xingye advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT binyao advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT mingyizhao advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT pengwu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT guihuanliu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT donglinzhuang advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT haodongjiang advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT xiaoweichen advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT yinruhe advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT shahuang advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration AT pingzhu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration |
_version_ |
1724252160691011584 |
spelling |
doaj-2a01c2602eb8404ebc5f272512f818252021-02-25T04:19:35ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2021-05-016513881401Advances in 3D bioprinting technology for cardiac tissue engineering and regenerationNanbo Liu0Xing Ye1Bin Yao2Mingyi Zhao3Peng Wu4Guihuan Liu5Donglin Zhuang6Haodong Jiang7Xiaowei Chen8Yinru He9Sha Huang10Ping Zhu11Department of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; Department of Cardiac Surgery, Affiliated South China Hospital, Southern Medical University (Guangdong Provincial People's Hospital) and The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, ChinaResearch Center for Tissue Repair and Regeneration affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College, 28 Fu Xing Road, Beijing, 100853, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; Department of Cardiac Surgery, Affiliated South China Hospital, Southern Medical University (Guangdong Provincial People's Hospital) and The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaResearch Center for Tissue Repair and Regeneration affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College, 28 Fu Xing Road, Beijing, 100853, China; Corresponding author.Department of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; Department of Cardiac Surgery, Affiliated South China Hospital, Southern Medical University (Guangdong Provincial People's Hospital) and The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China; Corresponding author. Department of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China.Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative medicine are greatly needed. The prominent development of tissue engineering using bioactive materials has creatively laid a direct promising foundation. Whereas, how to precisely pattern a cardiac structure with complete biological function still requires technological breakthroughs. Recently, the emerging three-dimensional (3D) bioprinting technology for tissue engineering has shown great advantages in generating micro-scale cardiac tissues, which has established its impressive potential as a novel foundation for cardiovascular regeneration. Whether 3D bioprinted hearts can replace traditional heart transplantation as a novel strategy for treating cardiovascular diseases in the future is a frontier issue. In this review article, we emphasize the current knowledge and future perspectives regarding available bioinks, bioprinting strategies and the latest outcome progress in cardiac 3D bioprinting to move this promising medical approach towards potential clinical implementation.http://www.sciencedirect.com/science/article/pii/S2452199X203027353D bioprintingStem cell therapyBioinkHeart repair and regeneration |